Close

Radius Health (RDUS) Moves to Session Highs as Rumors Continue

Go back to Radius Health (RDUS) Moves to Session Highs as Rumors Continue

Jefferies Boosts PT on Radius Health (RDUS) to $46 Amid Solid Physician Poll Data

August 15, 2016 8:43 AM EDT

Jefferies boosts its price target on Hold-rated Radius Health (Nasdaq: RDUS) from $37 to $46 today following recent physician poll results.

Analyst Eun Yang commented, Our physician poll shows convenient abalo-TD patch for osteoporosis, if successful, would increase abalo use by ~25-30% (vs. injectable abalo-SC). Given abalo-TD patch late-breaker presentation on 9/19/16 and likely positive... More

Radius Health (RDUS) Sees Early Gains on Continued Takeover Chatter

August 12, 2016 9:18 AM EDT

Radius Health (NASDAQ: RDUS) is up 2% in pre-open trade following another report from the Telegraph that the company is a target of takeover bids.

SI NOTE: This stock has been subject of renewed rumors over the past three sessions and in... More

Takeover Rumors Continue to Swirl Around Radius Health (RDUS)

August 11, 2016 9:38 AM EDT

Radius Health (NASDAQ: RDUS) is on watch amid continued takeover speculation. The FT reported rumors the company rejected a $70/share bid from Shire (NASDAQ: SHPG) and Shire is weighing raising its bid to $80. Shares of RDUS last traded up 1.1% to $52.55.

... More

Radius Health (RDUS) on Watch Amid Renewed Takeover Rumors

August 10, 2016 9:27 AM EDT

Radius Health (NASDAQ: RDUS) on watch amid renewed rumors the company is the target of a takeover bid.

... More